---
title: "Ranbaxy Laboratories Ltd (Merged) (RANBAXY) — Share Price, Financials & Analysis"
symbol: "RANBAXY"
company: "Ranbaxy Laboratories Ltd (Merged)"
canonical: "https://tapetide.com/stocks/RANBAXY"
nse_symbol: "RANBAXY"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
generated_at: "2026-09-13T18:46:36.637Z"
---

# Ranbaxy Laboratories Ltd (Merged) (RANBAXY)

Canonical page: https://tapetide.com/stocks/RANBAXY

## Company

- **NSE Symbol:** RANBAXY
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** DELISTED
- **Face Value:** ₹5
- **F&O Eligible:** No
- **Website:** ranbaxy.com

## About

Ranbaxy Laboratories Limited,Incorporated in India, listed on the Bombay Stock Exchange Limited, and National Stock Exchange Limited, the company is engaged in Pharmaceutical

## Latest Price

## Key Insights

### Strengths

- Debtor days have improved from 74.3 to 57.0 days.

### Weaknesses

- Stock is trading at 9.99 times its book value
- Company has low interest coverage ratio.
- Company has a low return on equity of 9.16% over last 3 years.

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| net income growth | -157% | — | 7% |
| revenue growth | 0% | 14% | 13% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2012 | Jun 2012 | Sep 2012 | Dec 2012 | Mar 2013 | Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 3781 | 3259 | 2708 | 2711 | 2472 | 2634 | 2802 | 2894 | 2467 | 2416 | 3260 | 2619 |
| Expenses | 2690 | 2998 | 2372 | 2658 | 2317 | 2511 | 2602 | 2624 | 2413 | 2286 | 2555 | 2506 |
| Operating Profit | 1091 | 261 | 336 | 53 | 155 | 123 | 199 | 270 | 54 | 130 | 705 | 113 |
| OPM % | 29 | 8 | 12 | 1.9 | 6 | 4.7 | 7 | 9 | 2.2 | 5 | 22 | 4.3 |
| Other Income | 405 | -530 | 459 | -289 | 144 | -451 | -346 | -119 | 89 | -181 | -5 | -5 |
| Interest | 19 | 165 | -16 | 136 | 53 | 159 | 111 | 121 | 114 | 142 | 137 | 147 |
| Depreciation | 80 | 78 | 0 | 80 | 80 | 0 | 133 | 92 | 0 | 0 | 0 | 97 |
| Profit before tax | 1398 | -512 | 811 | -453 | 167 | -487 | -391 | -60 | 30 | -192 | 563 | -135 |
| Tax % | 10 | 13 | 7 | 8 | 21 | 6 | 15 | 163 | 371 | -3 | 15 | 656 |
| Net Profit | 1248 | -584 | 757 | -489 | 130 | -523 | -453 | -162 | -79 | -189 | 477 | -1024 |
| EPS in Rs | 29.54 | -13.88 | 17.86 | -11.64 | 2.97 | -12.39 | -10.73 | -3.75 | -1.74 | -4.39 | 11.27 | -24.23 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Mar 2014 15m | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 5134 | 6057 | 6684 | 7296 | 7515 | 8876 | 10315 | 12452 | 13259 | 10762 |
| Expenses | 5022 | 5276 | 6143 | 8756 | 6924 | 7806 | 8861 | 10647 | 12281 | 9760 |
| Operating Profit | 112 | 781 | 540 | -1460 | 591 | 1070 | 1455 | 1805 | 977 | 1002 |
| OPM % | 2.2 | 13 | 8 | -20 | 8 | 12 | 14 | 14 | 7 | 9 |
| Other Income | 259 | 123 | 771 | 448 | 758 | 1463 | -3441 | 64 | -686 | -100 |
| Interest | 67 | 104 | 141 | 206 | 71 | 61 | 306 | 304 | 557 | 540 |
| Depreciation | 109 | 149 | 172 | 282 | 268 | 372 | 394 | 320 | 476 | 97 |
| Profit before tax | 194 | 651 | 999 | -1500 | 1010 | 2100 | -2686 | 1245 | -742 | 265 |
| Tax % | -36 | 21 | 21 | -38 | 69 | 28 | 7 | 24 | 45 | — |
| Net Profit | 264 | 515 | 787 | -943 | 307 | 1509 | -2890 | 932 | -1087 | -815 |
| EPS in Rs | — | 13.69 | 20.76 | -22.63 | 7.05 | 35.55 | -68.71 | 21.82 | -25.61 | -19.09 |
| Dividend Payout % | 121 | 62 | 41 | 0 | 0 | 6 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Mar 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 186 | 186 | 187 | 210 | 210 | 211 | 211 | 211 | 212 |
| Reserves | 2261 | 2400 | 2617 | 4086 | 4133 | 5394 | 2658 | 3873 | 3091 |
| Borrowings | 2004 | 3956 | 4142 | 4285 | 3630 | 4335 | 4491 | 4901 | 6598 |
| Other Liabilities | 1517 | 1891 | 2333 | 4656 | 4165 | 4205 | 8352 | 7466 | 4077 |
| Total Liabilities | 5969 | 8432 | 9278 | 13237 | 12137 | 14144 | 15712 | 16452 | 13978 |
| Fixed Assets | 2059 | 3895 | 4205 | 4490 | 4490 | 4548 | 4830 | 5008 | 5081 |
| CWIP | 560 | 358 | 357 | 471 | 623 | 382 | 227 | 208 | 303 |
| Investments | 17 | 36 | 240 | 543 | 541 | 498 | 98 | 79 | 72 |
| Other Assets | 3333 | 4143 | 4476 | 7733 | 6483 | 8716 | 10557 | 11157 | 8522 |
| Total Assets | 5969 | 8432 | 9278 | 13237 | 12137 | 14144 | 15712 | 16452 | 13978 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Mar 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 204 | 529 | 1023 | -152 | -162 | 1539 | 639 | 1582 | -3562 |
| Cash from Investing Activity | -838 | -1993 | -841 | -1776 | 54 | -2196 | 1781 | -1871 | 1958 |
| Cash from Financing Activity | 746 | 1513 | -39 | 2676 | -522 | 791 | -1218 | 237 | 1016 |
| Net Cash Flow | 112 | 49 | 143 | 749 | -631 | 134 | 1202 | -52 | -588 |
| Free Cash Flow | -704 | 109 | 587 | -586 | -653 | 1112 | 190 | 1117 | -4335 |
| CFO/OP | 213 | 59 | 215 | 1 | 14 | 202 | 59 | 105 | -323 |

### Ratios

| Item | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Mar 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 81 | 95 | 82 | 67 | 89 | 66 | 106 | 60 | 57 |
| Inventory Days | 224 | 248 | 220 | 234 | 219 | 266 | 286 | 246 | 209 |
| Days Payable | 127 | 130 | 116 | 133 | 171 | 230 | 156 | 146 | 111 |
| Cash Conversion Cycle | 178 | 213 | 186 | 168 | 137 | 102 | 236 | 159 | 154 |
| Working Capital Days | 113 | 124 | 104 | -24 | 32 | 53 | 1 | -18 | 56 |
| ROCE % | — | 14 | 16 | -18 | 12 | 21 | 15 | 21 | 7 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 0 / 7 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 123.54 | Sell |
| EMA (10) | 122.78 | Sell |
| SMA (20) | 129.76 | Sell |
| EMA (20) | 128.04 | Sell |
| SMA (50) | 141.55 | Sell |
| EMA (50) | 139.53 | Sell |
| SMA (100) | 158.65 | Sell |
| EMA (100) | 150.31 | Sell |
| SMA (200) | 162.16 | Sell |
| EMA (200) | 161 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 35.19 | Neutral |
| MACD (12,26,9) | -6.75 | Sell |
| Stochastic (14,3,3) | 31.2 | Neutral |
| ADX (14) | 18.56 | Neutral |
| Williams %R (14) | -72.85 | Neutral |
| ATR (14) | 5.75 | High Volatility |
| ROC (12) | -12.64 | Sell |
| Stoch RSI (14) | 33.99 | Neutral |
| UO (7,14,28) | 43.83 | Neutral |

## Filings & Documents

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2011 from nse](https://archives.nseindia.com/annual_reports/AR_RANBAXY_2010_2011_17062011050505.zip) |
| from nse | [Annual Report 2010 from nse](https://archives.nseindia.com/annual_reports/AR_RANBAXY_2010_2010_08082011082525.zip) |
| from bse | [Annual Report 2014 from bse](https://www.bseindia.com/bseplus/AnnualReport/500359/5003590314.pdf) |
| from bse | [Annual Report 2014 from bse](http://www.bseindia.com/bseplus/AnnualReport/500359/5003590314.pdf) |
| from bse | [Annual Report 2012 from bse](https://www.bseindia.com/bseplus/AnnualReport/500359/5003591212.pdf) |
| from bse | [Annual Report 2011 from bse](https://www.bseindia.com/bseplus/AnnualReport/500359/5003591211.pdf) |
| from bse | [Annual Report 2010 from bse](https://www.bseindia.com/bseplus/AnnualReport/500359/5003591210.pdf) |
| from bse | [Annual Report 2009 from bse](https://www.bseindia.com/HIS_ANN_RPT/HISTANNR/2009/RANBAXY_LABORATORIES_LTD-500359-MARCH-2009.PDF) |
| from bse | [Annual Report 2008 from bse](https://www.bseindia.com/HIS_ANN_RPT/HISTANNR/2008/RANBAXY_LABORATORIES_LTD-500359-MARCH-2008.PDF) |
| from bse | [Annual Report 2007 from bse](https://www.bseindia.com/HIS_ANN_RPT/HISTANNR/2007/RANBAXY_LABORATORIES_LTD-500359-MARCH-2007.PDF) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:46:36.637Z.